Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
Authors
L. Fan
A‐Yong Cao (ORCID: https://orcid.org/0000-0001-6241-1110)
Fan Yang (ORCID: https://orcid.org/0000-0001-8005-4997)
Science and Technology Commission of Shanghai Municipality
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
L. Fan, A‐Yong Cao, Fan Yang, Y Gong et al.
Citations
2 citations
Journal
BMJ
Topics
Breast Cancer Treatment Studies
Field-Weighted Citation Impact (FWCI)
1.87
article
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
L. Fan, A‐Yong Cao, Fan Yang, Y Gong, X. Zhu, Z. Shao, Yue Jiang, Mengting He, Li Chen, Zhen Hu, Yin Liu, Yi-Feng Hou, Can-Ming Chen, Guang-Yu Liu, Gen-Hong Di, Jun-Jie Li, Ke-Da Yu, Zhong-Hua Wang, Jiong Wu
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJVol. 391
Institutions
Shanghai Medical College of Fudan University (CN), Fudan University Shanghai Cancer Center (CN)
Funders
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Science and Technology Commission of Shanghai Municipality